Startseite » Mitarbeiter » Direktor » Weber » Publikationen

Publikationen

Originalarbeiten

 

1991-1994           Kum. Impact 41.8

1. Weber C, Aepfelbacher M, Lux I, Zimmer B, Weber PC (1991) Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increaseH in differentiated monocytic U937 cells. Biochim. Biophys. Acta. 1133:38-45. Impact 5.084
2. Ziegler-Heitbrock HWL, Käfferlein E, Haas JG, Meyer N, Ströbel M, Weber C, Flieger D (1992) Gangliosides suppress tumor necrosis factor production in human monocytes. J. Immunol. 148:1753-58. Impact 5.745
3. Weber C, Aepfelbacher M, Haag H, Ziegler-Heitbrock HWL, Weber PC (1993) Tumor necrosis factor induces enhanced responses to platelet activating factor and differentiation in human monocytic Mono Mac 6 cells. Eur. J. Immunol. 23:852-859. Impact 4.942
4. Weber C, Kruse HJ, Sellmayer A, Erl W, Weber PC (1993) Platelet activating factor enhances receptor-operated Ca2+-influx and subsequent prostacyclin-synthesis in human endothelial cells. Biochem. Biophys. Res. Commun. 195:874-880. Impact 2.595
5. Ziegler-Heitbrock HWL, Sternsdorf, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Baeuerle P, Ströbel M (1993) Pyrrolidine-dithiocarbamate inhibits NF-B mobilization and TNF production in human monocytes. J. Immunol. 151:6986-6993. Impact 5.745, 248 Zitationen
6. Sellmayer A, Goeßl C, Obermeier H, Volk R, Reeder E, Weber C, Weber PC (1994) Differential expression of eicosanoid synthesis in monocytic cells treated with retinoic acid and 1,25-dihydroxy-vitamin D3. Prostaglandins. 47:203-220. Impact 1.653
7. Ziegler-Heitbrock HWL, Schraut W, Wendelgaß P, Ströbel M, Sternsdorf T, Weber C, Aepfelbacher M, Haas JG (1994) Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6. J. Leukoc. Biol. 55:73-80. Impact 4.626
8. Weber C, Erl W, Pietsch A, Ströbel M, Ziegler-Heitbrock HWL, Weber PC (1994) Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-B mobilization and induction of vascular cell adhesion molecule 1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. Vasc. Biol. 14:1665-1673. Impact 7.215, 273 Zitationen
9. Haag H, Grünberg B, Weber C, Vauti F, Aepfelbacher M, Siess W (1994) Lovastatin inhibits receptor-stimulated Ca2+-influx of retinoic acid differentiated U937 and HL-60 cells. Cell. Signal. 7:735-742. Impact 4.243

 

 

1995           Kum. Impact 42.0

10. Weber C, Erl W, Weber PC (1995) Enhancement of monocyte adhesion to endothelial cells by modified low density lipoprotein is mediated via activation of CD11b. Biochem. Biophys. Res. Commun. 206:621-628. Impact 2.595
11. Weber C, Calzada-Wack JC, Goretzki M, Pietsch A, Johnson JP, Ziegler-Heitbrock HWL (1995) Retinoic acid inhibits basal and interferon- induced expression of intercellular adhesion molecule 1 in monocytic cells. J. Leukoc. Biol. 57:401-406. Impact 4.626
12.  Erl W, Weber C, Wardemann C, Weber PC (1995) Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes. Atherosclerosis 113:99-107. Impact 4.086
13. Weber C, Erl W, Pietsch A, Weber PC (1995) Aspirin inhibits NF-B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation. 91:1914-1917. Impact 14.429, 177 Zitationen
14. Weber C, Erl W, Pietsch A, Danesch U, Weber PC (1995) Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule 1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-. Arterioscler. Thromb. Vasc. Biol. 15:622-628. Impact 7.215, 101 Zitationen
15. Weber C, Negrescu E, Erl W, Pietsch A, Frankenberger M, Ziegler-Heitbrock HWL, Siess W, Weber PC (1995) Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J. Immunol. 155:445-451. Impact 5.745
16. Pietsch A, Weber C, Goretzki M, Weber PC, Lorenz RL (1995) N-3 but not n-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Cell Biochem. Funct. 13:211-216. Impact 1.651
17. Weber C, Erl W, Weber PC (1995) Lovastatin induces differentiation of Mono Mac 6 cells. Cell Biochem. Funct. 13:273-277. Impact 1.651

 

 

1996           Kum. Impact 34.1

18. Weber C, Erl W, Weber K, Weber PC (1996) Increased adhesiveness of isolated monocytes to en-dothelium is prevented by vitamin C intake in smokers. Circulation 93:1488-492. Impact 14.429, 114 Zitationen
19. Weber C, Alon R, Moser B, Springer TA (1996) Sequential regulation of 41 and 51 integrin avidity by CC chemokines in monocytes: Implications for transendothelial chemotaxis. J. Cell Biol. 134:1063-1073. Impact 9.921, 169 Zitationen
20. Weber C, Kitayama J, Springer TA (1996) Differential regulation of 1 and 2 integrin avidity by chemoattractants in eosinophils. Proc. Natl. Acad. Sci. USA. 93: 10939-944. Impact 9.771, 159 Zitationen

 

 

1997           Kum. Impact 53.8

21. Sellmayer A, Obermeier H, Weber C (1997) Intrinsic cyclooxygenase activity is not required for monocytic differentiation of U937 cells. Cell Signal. 9:91-96. Impact 4.243
22. Erl W, Weber C, Wardemann C, Weber PC (1997) -Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-B mobilization and adhesion molecule expression. Am. J. Physiol. 273: H634-H640. Impact 3.817
23. Weber C, Lu CF, Casasnovas JM, Springer TA (1997) Role of L2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J. Immunol. 159:3968-3975. Impact 5.745
24. Kupatt C, Weber C, Wolf DA, Becker BF, Smith TW, Kelly RA (1997) Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NF-B. J. Mol. Cell. Cardiol. 29:2599-2609. Impact 5.499
25. Weber C, Springer TA (1997) Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to IIb3 and stimulated by platelet activating factor. J. Clin. Invest. 100:2085-2093. Impact 14.152, 176 Zitationen
26. Weber C, Erl W, Weber KSC, Weber PC (1997) HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from hypercholesterolemic patients. J. Am. Coll. Cardiol. 30:1212-1217 (comment in J. Am. Coll. Cardiol. 30:1218). Impact 14.292, 264 Zitationen
27. Kupatt C, Habazettl H, Zahler S, Weber C, Becker BF, Messmer K, Gerlach E (1997) ACE inhibition prevents leukocyte-dependent reperfusion injury by reducing coronary leukocyte adhesion. Cardiovasc. Res. 36:386-395. Impact 6.051

 

 

1998           Kum. Impact 19.7

28. Piali L, Weber C, La Rosa G, Mackay CR, Springer TA, Clark-Lewis I, Moser B (1998) The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 28:961-972. Impact 4.942, 149 Zitationen
29. Erl W, Weber PC, Weber C (1998) Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis. 136:297-303. Impact 4.086
30. Weber KSC, Klickstein L, Weber PC, Weber C (1998) Chemokine-induced monocyte transmigra¬tion requires cdc42-mediated cytoskeletal changes. Eur. J. Immunol. 28:2245-2251. Impact 4.942
31. Weber C, Springer TA (1998) Interaction of VLA-4 with VCAM-1 supports transendothelial che-motaxis of monocytes by facilitating lateral migration. J. Immunol. 161:6825-834. Impact 5.745

 

 

1999           Kum. Impact 56.1

32. Neuzil J, Sorensen I, Weber T, Weber C, Brunk U (1999) Tocopheryl succinate-induced apoptosis of Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett. 445:295-300. Impact 3.601
33. Weber KSC, von Hundelshausen P, Weber PC, Clark-Lewis I, Weber C (1999) Differential chemokine immobilization and hierarchical involvement of their receptors in monocyte arrest and transmigration on inflammatory endothelium. Eur. J. Immunol. 29:700-12. Impact 4.942, 116 Zitationen
34. Draude G, von Hundelshausen P, Frankenberger M, Ziegler-Heitbrock HWL, Weber C (1999) Distinct scavenger receptor expression and function in the CD14+CD16+ human blood monocyte subsets. Am. J. Physiol. 276:H1144-H1149. Impact 3.817
35. Erl W, Hansson GK, de Martin R, Draude G, Weber KSC, Weber C (1999) Nuclear factor-B regulates apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ. Res. 84:668-677. Impact 9.504, 118 Zitationen
36. Weber KSC, Klickstein LB, Weber C (1999) Specific activation of the 2 integrins Mac-1 and LFA-1 by chemokines in mononuclear cells mediated by distinct activation pathways via the  subunit cytoplasmic domains. Mol.  Biol. Cell. 10:861-873. Impact 5.861
37. Weber KSC, Draude G, Erl W, de Martin R, Weber C (1999) Monocyte arrest and transmigration on inflamed endothelium in shear flow is inhibited by adenoviral gene transfer of IB-. Blood 93:3685-3693. Impact 10.558
38. Weber C, Draude G, Weber KSC, Wübert J, Lorenz R, Weber PC (1999) Downregulation by tumor necrosis factor- of monocyte CCR2 expression and MCP-1-induced transendothelial chemotaxis is antagonized by oxidized LDL: a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis 145:115-123. Impact 4.086
39. Gröne HJ, Weber C, Weber KS, Gröne EF, Rabelink J, Klier C, Wells TN, Proudfoot A, Schlöndorff D, Nelson PJ (1999) MetRANTES reduces vascular and tubular damage during acute vascular rejection: blocking monocyte arrest and recruitment. FASEB J. 13:1371-1383. Impact 6.515, 167 Zitationen
40. Weber KSC, Nelson PJ, Gröne HJ, Weber C (1999) Expression of CCR2 by endothelial cells: implications for MCP-1-mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler. Thromb. Vasc. Biol. 19:2085-2093. Impact 7.215, 125 Zitationen

 

 

2000 Kum. Impact 8.4

41. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, Mack M, Frankenberger M, Weber KSC, Ziegler-Heitbrock HWL (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67:699-704. Impact 4.626
42. Erl W, Weber C, Hansson GK (2000) Susceptibility to apoptosis induced by pyrrolidine dithiocarbamate is dependent on cell type, density and copper/zinc ions. Am. J. Physiol. Cell Physiol. 278:C1116-1125. Impact 3.817

 

 

2001         Kum. Impact 105.5

43. Neuzil J, Weber T, Gellert N, Weber C (2001) Selective cancer cell killing by -tocopheryl succinate. Brit. J. Cancer 84:87-89. Impact 4.831
44. Neuzil J, Weber T, Schröder A, Lu M, Olejnicka B, Ostermann G, Gellert N, Mayne GC, Negre-Salvayre A, Sticha M, Coffey RJ, Weber C (2001) Induction of cancer cell apoptosis by -tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 15:403-15. Impact 6.515, 127 Zitationen
45. Weber C, Weber KSC, Klier C, Gu H, Horuk R, Wank R, Nelson PJ (2001) Specialized roles of the chemokine receptors CCR1 and CCR5 in recruitment of monocytes and Th1-like/CD45RO+ T cells. Blood 97:1144-1146 (comment in Blood 97:833). Impact 10.558, 103 Zitationen
46. Horuk R, Clayberger C, Krensky AM, Wang Z, Gröne HJ, Weber C, et al. (2001) A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J. Biol. Chem. 276:4199-4204. (Impact 5.328) Impact 5.328
47. von Hundelshausen P, Weber KSC, Huo YQ, Proudfoot A, Nelson PJ, Ley K, Weber C (2001) Deposition of RANTES by platelets triggers monocyte recruitment on inflamed and atherosclerotic endothelium. Circulation 103:1772-1777 (comment in Circulation 103:1718) Impact 14.429, 208 Zitationen
48. Neuzil J, Schröder A, von Hundelshausen P, Zernecke A, Weber T, Gellert N, Weber C (2001) Inhibition of endothelial inflammatory responses by subapoptotic caspase activation and p65 cleavage. Biochemistry 40:4686-4692. (Impact 3.226) Impact 3.226
49. Zernecke A, Weber KSC, Erwig LP, Kluth DC, Schröppel B, Rees A, Weber C (2001) Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXCR2 in infiltration during nephrotoxic nephritis. J. Immunol. 166:5755-5762. Impact 5.745
50. Weber C, von Stülpnagel C, Weber KSC, Hengel H, Weber PC (2001) Association of myocardial infarction with mononuclear cell expression of the CMV chemokine receptor US28 in NIDDM patients. Exp. Clin. Cardiol. 6:105-108. Impact 0.200
51. Haritoglou C, Müller-Schunk S, Weber C, Hoffmann U, Ulbig MW (2001) Central retinal artery occlusion in association with an aneurysm of the internal carotid artery. Am. J. Ophthalmol. 132:270-271. Impact 4.293
52. Weber KSC, Nelson P, Röcken H, Klier C, Gu H, Proudfoot A, Wank R, Weber C (2001) Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral MIP-II. Eur. J. Immunol. 31:2458-2466. Impact 4.942
53. Alleva R, Tomaselli M, Gellert N, Weber C, Murphy MP, Neuzil J (2001) Coenzyme Q blocks biochemical but not receptor-mediated apoptosis by increasing mitochondrial antioxidant protection. FEBS Lett. 503:46-50. Impact 3.601
54. Erl W, Weber KSC, Weber PC, Weber C (2001) Transient increase in monocyte adhesion to endothelium by a single dose of simvastatin. Atherosclerosis 158:491-493. Impact 4.086
55. Weber C, Tato F, Brandl T, Kellner W, Hoffmann U (2001) Adult moyamoya disease with peripheral artery involvement. J. Vasc. Surgery 34: 943-946. Impact 3.851
56. Weber KSC, Ostermann G, Zernecke A, Schröder A, Klickstein LB, Weber C (2001) Dual role of H-ras in regulation of LFA-1 activity by SDF-1: implications for leukocyte transmigration. Mol. Biol. Cell 12:3074-3086. Impact 5.861
57. Huo YQ, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, Jung S, Littman DR, Ley K (2001) The chemokine KC but not MCP-1 triggers arrest of monocytes in carotid arteries with early atherosclerotic lesions. J. Clin. Invest. 108:1307-14 (see also J. Clin. Invest. 108:1269). Impact 14.152, 128 Zitationen
58. Zernecke A, Weber KSC, Weber C (2001) Combined modulation of the mesangial machinery for monocyte recruitment by inhibition of NF-B. Am. J. Physiol. Cell Physiol. 188:C1881-88. Impact 3.817
59. Weber KSC*, Weber C*, Ostermann G, Nagel W, Dierks H, Kolanus W (2001) Cytohesin-1 is a dynamic regulator of distinct LFA-1 functions in arrest and transmigration triggered by chemokines during leukocyte recruitment. Curr. Biol. 11:1969-1974. * equal contribution. Impact 10.025

 

 

2002           Kum. Impact 60.0

60. Jostarndt K, Gellert N, Rubic T, Weber C, Kühn H, Johansen B, Hrboticky N, Neuzil J (2002) Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified LDL in monocytic cells. Biochem. Biophys. Res. Comm. 290:988-993. Impact 2.595
61. Ostermann G, Weber KSC, Zernecke A, Schröder A, Weber C (2002) JAM-1 is a ligand for the 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunol. 3:151-158 (comment in Nature Immunol. 3:116). Impact 25.668, 276 Zitationen
62. Neuzil J, Zhao M, Ostermann G, Kagedal K, Sticha M, Gellert M, Weber C, Eaton J, Brunk UT (2002) -Tocopheryl succinate, an agent with in vivo anti-tumour activity induces apoptosis by causing lysosomal instability. Biochem. J. 362:709-715. Impact 5.016
63. Mack M, Pfirstinger J, Weber C, Weber KSC, Nelson PJ, Rupp T, Maletz K, Brühl H, Schlöndorff D (2002) Chondroitin sulfate A released from platelets blocks RANTES presentation and RANTES-dependent firm adhesion of leukocytes. Eur. J. Immunol. 32:1012-20. Impact 4.942
64. Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schröder A, Erl W, Brunk U, Coffey RJ, Weber C, Neuzil J (2002) Vitamin E succinate is a potent novel anti-neoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis inducing ligand in vivo. Clin. Cancer Res. 8:863-869. Impact 7.338
65. Schober A, Manka D, von Hundelshausen P, Huo YQ, Hanrath P, Sarembock IJ, Ley K, Weber C (2002) Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106:1523-1529 (comment in Circulation 106:1433). Impact 14.429, 126 Zitationen

 

 

2003           Kum. Impact 77.7

66. Buss J, Neuzil J, Gellert N, Weber C, Ponka P (2003) Pyridoxal isonicotinoyl hydrazones induce apoptosis in hematopoetic cells due to their iron-chelating properties. Biochem. Pharmacol. 65:161-172. Impact 4.889
67. Huo YQ, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in apolipoprotein E deficient mice. Nature Med. 9:61-67. Impact 25.430, 351 Zitationen
68. Schmid H, Schubert S, Weber C, Bogner J (2003) Isolation of a pantoea dispersa strain from a 71 year old woman with acute myeloid leukemia and multiple myeloma. Infection 31:66-67. Impact 2.244
69. Weber T, Dalen H, Andera L, Negre-Salvayre A, Sticha M, Loret A, Terman A, Witting PK, Higuchi M, Zivny J, Gellert N, Weber C, Neuzil J (2003) Mitochondria play a central role in apoptosis induced by -tocopheryl succinate, an agent with antineoplastic activity: comparison  with receptor-mediated pro-apoptotic signaling. Biochemistry 42:4277-4291. Impact 3.226
70. Zernecke A, Erl W, Fraemohs L, Lietz M, Weber C (2003) Suppression of endothelial adhesion molecule upregulation with cyclopentenone prostaglandins is dissociated from IB- kinase inhibition and cell death induction. FASEB J. 17:1099-1101. Impact 6.515
71. Ortlepp JR, Vesper K, Mevissen V, Schmitz F, Janssens U, Franke A, Hanrath P, Weber C, Zerres K, Hoffmann R (2003) Chemokine receptor CCR2 genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J. Mol. Med. 81:363-367. Impact 5.192
72. Baltus T, Weber KSC, Johnson Z, Proudfoot AEI, Weber C (2003) Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes. Blood 102:1085-1088. Impact 10.558
73. Ortlepp JR, Metrikat J, Vesper K, Mevissen V, Schmitz F, Albrecht M, Maya-Pelzer P, Hanrath P, Weber C, Zerres K, Hoffmann R (2003) The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J. Mol. Med. 81:578-584. Impact 5.192
74. Schober A, Knarren S, Lin E, Lietz M, Guttenbach M, Weber C (2003) Crucial role of stromal cell-derived factor-1 in neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation 108:2491-2497. Impact 14.429

 

 

2004         Kum. Impact 123.2

75. Erl W, Weber C, Zernecke A, Neuzil J, Vosseler CA, Kim HJ, Weber PC (2004) Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-. Eur. J. Immunol. 34:241-250. Impact 4.942
76. Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, Weber C (2004) Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109:380-5. Impact 14.429
77. Blindt R, Bosserhoff AK, Dammers J, Krott N, Demircan L, Hoffmann R, Hanrath P, Weber C, Vogt F (2004) Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by rhoA deactivation. Cardiovasc. Res. 62:212-222 Impact 6.051
78. Ortlepp JR, Schmitz F, Mevissen V, Weiss S, Huster J, Dronskowski R, Langebartels G, Autschbach R, Zerres K, Weber C, Hanrath P, Hoffmann R (2004) The amount of calcium-deficient hexagonal hydroxyl-apatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur. Heart J. 25:514-52. Impact 10.046
79. Jostarndt K, Rubic T, Kühn H, Anthosen MW, Andera L, Gellert N, Trottmann M, Weber C, Johansen B, Hrboticky N, Neuzil J (2004) Enzymatically modified LDL upregulates CD36 in low-differentiated monocytic cells in a PPAR--dependent way. Biochem. Pharmacol. 67:841-854. Impact 4.889
80. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ, Weber C (2004) Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ. Res. 94:776-784. (comment in Circ. Res. 94:706) Impact 9.504
81. Skobel E, Schuh A, Lin E, Schwarz ER, Reffelmann T, Franke A, Breuer S, Günther K, Hanrath P, Weber C (2004) Transplantation of fetal cardiomyocytes into infarcted rat heart results in long-term functional improvement. Tissue Engineering 10:849-864. Impact 4.636
82. Merx MW, Lin EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C (2004) HMG-CoA-reductase inhibitor simvastatin profoundly improves survival in sepsis. Circulation 109:2560-2565. Impact 14.429
83. Hoffmann R, Langenberg R, Radke PW, Franke A, Ortlepp J, Weber C, Hanrath P (2004) Evaluation of a high-dose dexamethasone eluting stent. Am. J. Cardiol. 94:193-5.  () Impact 3.680
84. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, Bosserhoff AK, Michaeli W, Weber C, Blindt R (2004) A novel biodegradable coronary polymer stent with drug-delivery capacities: paclitaxel-loading inhibits neointimal hyperplasia in a porcine model of coronary restenosis. Eur. Heart J. 25:1330-40. Impact 10.046
85. Weissenbach M, Clahsen T, Weber C, Spitzer D, Wirth D, Vestweber D, Heinrich PC, Schaper F (2004) Interleukin-6 is a direct mediator of T cell migration. Eur. J. Immunol. 34:2895-2904. () Impact 4.942
86. Liehn EA, Schober A, Weber C (2004) Blockade of KC inhibits re-endothelialization and enhances plaque formation after arterial injury in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24:1891-1896. Impact 7.215
87. Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C (2004). The functional interaction of the 2 integrin LFA-1 with junctional adhesion molecule-A is mediated by the I-domain. J. Immunol. 173:6259-6264 Impact 5.745
88. Koszalka P, Özüyaman B, Huo Y, Zernecke A, Flögel U, Braun N, Buchheiser A, Decking UK, Smith ML, Sévigny J, Gear A, Weber A, Molojavyi A, Ding ZP, Zimmermann H, Weber C, Ley K, Gödecke A, Schrader J (2004) Targeted disruption of cd73/ecto-5´-nucleotidase alters thrombo-regulation and augments vascular inflammatory response. Circ. Res. 95:814-821. (comment in Circ. Res. 95:752) Impact 9.504
89. Schober A, Zernecke A, Liehn E, von Hundelshausen P, Knarren S, Kuziel WA, Weber C (2004) The crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in atherosclerosis-prone mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ. Res. 95:1125-1133. Impact 9.504
90. Hoffmann R, Radke PW, Ortlepp JR, Haager PK, Blindt R, Iofina E, Franke A, Weber C, Hanrath P (2004) Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced  by 4 different stents in the coronary arteries. Am. J. Cardiol. 94:1548-1550. Impact 3.680

 

 

2005           Kum. Impact 82.6

 

91. von Hundelshausen P, Koenen RR, Sack M, Mause SF, Proudfoot AEI, Adriaens W, Hackeng TM, Weber C (2005) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105:924-930. (Impact 10.558)

 

92. Furnkranz A, Schober A, Bochkov V, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N (2005) Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler. Thromb. Vasc. Biol. 25:633-8. (Impact 7.215)

 

93. Schuh A, Breuer S, Al Dashti R, Sulemanjee N, Hanrath P, Weber C, Uretsky BF, Schwarz ER (2005) Administration of VEGF adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J. Cardiovasc. Pharmacol. Ther. 10:55-66. (Impact 1.969)

 

94. Ostermann G, Fraemohs L, Baltus T, Schober A, Lietz M, Zernecke A, Weber C (2005) Involvement of junctional adhesion molecule-A (JAM-A) in mononuclear cell recruitment on inflamed or athero7.215sclerotic endothelium: inhibition by soluble JAM-A. Arterioscler. Thromb. Vasc. Biol. 25:729-735. (Impact 7.215)

 

95. Ortlepp JR, Graf J, Vesper K, Schmitz F, Mevissen V, Sucigan S, Kersten A, Weber C, Janssens U (2005) Relationship of five inflammatory gene polymorphisms with morbidity and mortality in 533 patients admitted to an ICU. Inflammation 29:1-7. (Impact 1.777)

 

96. Zernecke A, Schober A, von Hundelshausen P, Liehn EA, Möpps B, Mericskay M, Gierschik P, Biessen EA, Weber C (2005) SDF-1/CXCR4 axis is instrumental for neointimal hyperplasia and recruitment of smooth muscle cell progenitors. Circ. Res. 96:784-791. (Impact 9.504)

 

97. Merx M, Zernecke A, Liehn EA, Schuh A, Skobel E, Butzbach B, Hanrath P, Weber C (2005) Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic  Res. Cardiol. 100:208-16. (Impact 6.128)

 

98. Mause SF, von Hundelshausen P, Zernecke A, Koenen R, Weber C (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on inflamed and atherosclerotic endothelium. Arterioscler. Thromb. Vasc. Biol. 25:1512-18. (Impact 7.215)

 

99. Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, Hanrath P, Weber C (2005) Statin treatment after onset of sepsis in a murine model improves survival, Circulation 112:117-124. (Impact 14.429)

 

100. Baltus T, von Hundelshausen P, Mause S, Buhre W, Rossaint R, Weber C (2005) Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J. Leukoc. Biol. 78:435-441. (Impact 4.626)

 

101. Schober A, Hoffmann R, Opree N, Knarren S, Iofina E, Hutschenreuter G, Hanrath P, Weber C (2005) Peripheral CD34+ cells and the risk of restenosis after coronary stent placement. Am J. Cardiol. 96:1116-1122. (Impact 3.680)

 

102. Merx MW, Schäfer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C, Ketteler M, Jahnen-Dechent W (2005) Cardiac remodeling and diastolic dysfunction in fetuin-A deficient mice. J. Am. Soc. Nephrol. 16:3357-64. (Impact 8.288)

 

2006           Kum. Impact 65.4

 

103. Burger-Kentischer A, Göbel H, Kleemann R, Zernecke A, Bucala R, Leng L, Finkelmeier D, Geiger G, Schaefer HE, Schober A, Weber C, Brunner H, Rütten H, Ihling C, Bernhagen J (2006) Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor. Atherosclerosis 184:28-38. (Impact 4.086)

 

104. Koch KC, Liehn E, Rammos C, Müller D, Schröder J, Dimassi T, Stopinski T, Schäfer W, Weber C (2006) Effect of catheter-based transendocardial delivery of SDF-1a on left ventricular function and perfusion in a porcine model of myocardial infarction. Basic Res. Cardiol. 101:69-77 (Impact 6.128)

 

105. Zernecke A, Liehn EA, von Hundelshausen P, Fraemohs L, Krohn R, Corada M, Dejana E, Weber C (2006) Importance of JAM-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 26:e10-13. (Impact 7.215)

 

106. Hoffmann R, Suliman H, Haager P, Christott P, Lepper W, Radke PW, Ortlepp J, Blindt R, Hanrath P, Weber C (2006) Association of C-reactive protein and myocardial perfusion in patients with acute myocardial infarction. Atherosclerosis 186:177-183. (Impact 4.086)

 

107. Zernecke A, Bidzhekov K, Özüyaman B, Liehn EA, Fraemohs L, Firzlaff-Lüscher J, Lüscher B, Schrader J, Weber C (2006) CD73/ecto-5’-nucleotidase protects against vascular inflammation and neointima formation. Circulation 113:2120-27 (Impact 14.429)

 

108. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C (2006) A novel drug-eluting stent coated with an integrin-binding cRGD peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J. Am. Coll. Cardiol. 47:1786-1795. (Impact 14.292)

 

109. Zernecke A*, Liehn EA*, Gao JL, Murphy PM, Kuziel WA, Weber C (2006) Deficiency in CCR5 but not in CCR1 protects from neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood. 107:4240-4243. * equal contribution. (Impact 10.558)

 

110. Hristov M, Heussen N, Schober A, Weber C (2006) Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J. Cell. Mol. Med. 10:727-733. (Impact 4.608)

 

2007         Kum. Impact 146.6

 

111. Lucerna M, Zernecke A, de Nooijer R, de Jager S, Bot I, van der Lans C, Kholova I, van Berkel TJC, Ylä-Herttuala S, Weber C, Biessen EAL (2007) Vascular endothelial growth factor induces plaque expansion in ApoE knockout mice by promoting de novo leukocyte recruitment. Blood 109:122-129. (comment in Blood 109:2-3) (Impact 10.558)

 

112. Hristov M , Fach C, Becker C, Heussen N, Liehn EA, Blindt R, Hanrath P, Weber C (2007) Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192:413-420. (Impact 4.086)

 

113. Braunersreuther V, Zernecke A, Steffens S, Burger F, Pelli G, Luckow B, Mach F, Weber C  (2007) CCR5 but not CCR1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27:373-9. (Impact 7.215)

 

114.  Nowak B, Weber C, Schober A, Zeiffer U, Liehn EA, von Hundelshausen P, Reinartz P, Buell U (2007) 111Indium-oxine labeling affects cellular integrity of hematopoietic progenitor cells. Eur. J. Nucl. Med. Mol. Imaging 34:715-721. (Impact 5.036)

 

115. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, Weber C (2007) Importance of CXCR2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100:590-597. (Impact 9.504)

 

116. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a non-cognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell re¬cruitment. Nat. Med. 13:587-596. (comment in Nat. Rev. Drug Dis. 6:435) (Impact 25.430, 180 Zitationen)

 

117. Bot I, de Jager SCA, Zernecke A, Weber C, van Berkel TJC, Biessen EAL (2007) Perivascular mast cell activation aggravates atherogenesis and contributes to plaque destabilization in ApoE-/- mice. Circulation 115:2516-2525. (comment in Circulation 115: 2471) (Impact 14.429)

 

118.  Segerer S, Djafarzadeh R, Gröne HJ, Weinghart C, Kerjaschki D, Weber C, Regele H, Kungl AJ, Proudfoot AEI, Nelson PJ (2007) Selective binding and presentation of CCL5 by discrete tissue microenvironments during inflammation. J. Am. Soc. Nephrol. 18:1835-44. (Impact 8.288)

 

119. Hundhausen C, Schulte A, Schulz B, von Hundelshausen P, Achilles J, Winter U, Paliga K, Reiss K, Weber C, Ludwig A (2007) Regulated shedding of transmembrane chemokines by the metallo¬proteinase ADAM10 facilitates detachment of adherent leukocytes. J. Immunol. 178:8064-72. (Impact 5.745)

 

120. Schulte A, Schulz B, Hundhausen C, Andrzejewski MM, Mletzko S, Achilles J, Reiss K, Paliga K, Weber C, Rose-John S, Ludwig A (2007) Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by - and -secretases. Biochem. Biophys. Res. Commun. 358:233-40. (Impact 2.595)

 

121. Redondo S, Hristov M, Gümbel D, Tejerina T, Weber C (2007) Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of PPAR- and TGF-. Thromb. Haemostasis 6:979-987. (Impact 4.701)

 

122. Galkina E, Harry B, Ludwig A, Liehn E, Sanders J, Bruce A, Weber C, Ley K (2007) CXCR6 promotes atherosclerosis by supporting T cell homing, interferon- production and macrophage accumulation in the aortic wall. Circulation 116:1801-1811. (Impact 14.429)

 

123. Krohn R, Raffetseder U, Bot I, Zernecke A, Shagdarsuren E, Liehn EA, van Santbrink PJ, Nelson PJ, Biessen EA, Mertens PR, Weber C (2007) YB-1 controls CCL5 expression in smooth muscle cells and contributes to neointima formation in atheroslerosis-prone mice. Circulation 116:1812-20. (Impact 14.429)

 

124. Dewor M, Krohn R, Steffens G, Baron J, Weber C, Bernhagen J (2007) Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in wounded monolayers in vitro. FEBS Letters 581:4734-42. (Impact 3.601)

 

125. Karshovska E, Zernecke A, Sevilmis G, Millet A, Cohen C, Schmid H, Sohn HY, Weber C, Schober A (2007) Expression of HIF-1 in injured arteries controls SDF-1-mediated neointima formation in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27:2540-7. (Impact 7.215)

 

126. Bidzhekov K, Hautmann M, Semisch M, Weber C, Engelmann B, Hatzopoulos A (2007) Rafs as nodal points in the regulation of endothelial progenitor cell growth and differentiation. J. Cell Mol. Med. 11:1395-1407. (Impact 4.608)

 

127. Blindt R, Iofina K, de Taeye A, Müller R, Kiefer P, Weber C, Kelm M, Hoffmann R (2007) The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. Thromb. Haemostasis 98:1329-1334. (Impact 4.701)

 

2008         Kum. Impact 169.6

 

128. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, Merx MW, Weber C (2008) Transplantation of endothelial progenitor cells improves neovascularization and myocardial function in a rat model. Basic Res. Cardiol. 103:69-77. (Impact 6.128)

 

129. Shagdarsuren E, Bidzhekov K, Liehn EA, Djalali-Talab Y, Hristov M, Matthijsen RA, Buurman WA, Zernecke A, Weber C (2008) C1-esterase inhibitor protects against neointima formation after arterial injury in athero¬sclerosis-prone mice. Circulation 117:70-78. (Impact 14.429)

 

130. Zernecke A, Bot I, Djalali Talab Y, Shagdarsuren E, Meiler S, Liehn EA, Schober A, Soehnlein O, Sperandio M, Tacke F, Biessen EA, Weber C (2008) Protective role of Cxcr4/Cxcl12 unveils the importance of neutro¬phils in atherosclerosis. Circ. Res. 102:209-217. (comment in Circ. Res. 102:154-156) (Impact 9.504)

 

131. Liehn EA, Merx MW, Postea O, Becher S, Djalali Talab Y, Shagdarsuren E, Kelm M, Zernecke A, Weber C (2008) Ccr1 deficiency reduces neutrophil infiltration, limits infarct size and improves left ventricular function after myocardial infarction. J. Cell. Mol. Med. 12:496-506 (Impact 4.608)

 

132. Donners MMPC, Beckers L, Lievens D, Munnix I, Heemskerk J, Janssen BJ, Wijnands E, Cleutjens J, Zernecke A, Weber C, Ahonen CL, Benbow U, Newby AC, Noelle RJ, Daemen MJAP, Lutgens E (2008) The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodelling. Blood 111:4596-604. (Impact 10.558)

 

133. Redondo S, Gordillo-Moscoso AA, Ruiz E, Hristov M, Weber C, Tejerina T (2008) High-reproducible endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte population. J. Immunol. Methods 335:21-7. (Impact 2.340)

 

134. Frommhold D, Ludwig A, Bixel G, Zarbock A, Babushkina I, Lange-Sperandio B, Ellies LG, Marth JD, Beck-Sickinger AG, Linderkamp O, Zernecke A, Weber C, Vestweber D, Ley K, Sperandio M (2008) Sialyl¬transferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J. Exp. Med. 205:1435-46. (Impact 14.776)

 

135. Lukowski R, Weinmeister P, Bernhard D, Feil S, Gotthardt M, Herz J, Massberg S, Zernecke A, Weber C, Hofmann F, Feil R (2008) Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis. Arterioscler. Thromb. Vasc. Biol. 28:1244-50. (Impact 7.215)

 

136. Vogt F, Zernecke A, Beckner M, Krott N, Bosserhoff AK, Hoffmann R, Jahnke T, Kelm M, Weber C, Blindt R (2008) Blocking of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation after vascular injury in hyperlipidemic apolipoprotein E knock-out mice. J. Am. Coll. Cardiol. 52:302-11. (comment in J. Am. Coll. Cardiol. 52:312–314) (Impact 14.292)

 

137. Schlieper G*, Hristov M*, Brandenburg V, Krüger T, Westenfeld R, Mahnken AH, Yagmur E, Boecker G, Heussen N, Gladziwa U, Ketteler M, Weber C, Floege J (2008) Predictors of low circulating endothelial pro¬genitor cell numbers in hemodialysis patients. Nephrol. Dial. Transplant. 23:2611-8. *equal contribution. (Impact 3.564)

 

138. Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112:1461-71. (Impact 10.558)

 

139. Pluskota E, Soloviev DA, Szpak D, Weber C, Plow EF (2008) Neutrophil apoptosis: selective regulation by different ligands of integrin M2.  J. Immunol. 181:3609-19. (Impact 5.745)

 

140. Jacoby C, Böring YC, Beck A, Zernecke A, Aurich V, Weber C, Schrader J, Flögel U (2008) Dynamic changes in murine vessel geometry assessed by high resolution magnetic resonance angiography: a 9.4 T study. J. Magn. Res. Imaging 28:637-645. (Impact 2.747)

 

141. Weber C, Kraemer S, Drechsler M, Lue H, Koenen R, Kapurniotu A, Zernecke A, Bernhagen J (2008) Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc. Natl. Acad. Sci. USA. 105:16278-16283. (Impact 9.771)

 

142. Postea O, Koenen RR, Hristov M, Weber C, Ludwig A (2008) Homocysteine upregulates vascular trans-membrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo. J. Cell. Mol. Med. 12:1700-1708. (Impact 4.608)

 

143. Karshovska E, Zagorac D, Zernecke A, Klauss V, Weber C, Schober A (2008) A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J. Thromb. Haemost. 10:1812-1815  (Impact 5.439)

 

144. Spyridopoulos I, Fichtlscherer S, Popp R, Toennes SW, Trepels T, Zernecke A, Liehn EA, Weber C, Zeiher AM, Dimmeler S, Haendeler J (2008) Caffeine enhances endothelial repair by an AMPK-dependent mechanism. Arterioscler. Thromb. Vasc. Biol. 28:1967-74. (Impact 7.215)

 

145. Choi EY, Chavakis E, Czabanka MA, Langer H, Fraemohs L, Economopoulou M, Orlandi A, Kundu RK, Zheng YY, Ballantyne CM, Constant SL, Aird W, Papayannopoulou T, Gahmberg C, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T (2008) Del-1 is an endogenous inhibitor of leukocyte-endo¬thelial adhesion preventing inflammatory cell recruitment. Science 322:1101-4. (comment in Nat. Rev. Immunol. 9:6-7) (Impact 31.364)

 

146. Dragomir E, Manduteanu I, Calin M, Gan AM, Stan D, Koenen RR, Weber C, Simionescu M (2008) High glucose condition induces an inflammatory up-regulation of fractalkine and MCP-1 in human smooth muscle cells. Thromb. Haemost. 100:1155-65. (Impact 4.701)

 

2009         Kum. Impact 147.0

 

147. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp B, Piccinini A, Kowalska A, Kungl AJ, Hackeng TM, Mayo KH, Weber C (2009) Disrupting functional inter¬actions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15:97-103. (Impact 25.430)

 

148. Raffetseder U, Djudjaj S, Rauen T, Frye BC, Kretzler M, Kunter U, Floege J, Nelson P, Weber C*, Mertens PR* (2009) Differential regulation of chemokine CCL5 expression in monocytic/macrophage and renal cells is orchestrated by YB-1. Kidney Int. 75:185-196. *equal contribution. (Impact 6.105)

 

149. Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C, Moy VT (2009) LFA-1 binding de¬stabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys. J. 96:285-293. (Impact 4.218)

 

150. Landsman L*, Ber-On L*, Zernecke A*, Kim KW, Krautgamer R, Shagdarsuren E, Lira SA, Weisman IL, Weber C, Jung S (2009) CX3CR1-mediated cell survival in monocyte homeostasis and atherogenesis. Blood 113:963-972. (comment in Blood 113:767-768) *equal contribution. (Impact 10.558)

 

151. Rana OR, Saygili E, Meyer C, Schotten U, Weis J, Krüttgen A, Nolte KW, Andrzejewski MG, Ludwig A, Weber C, Schwinger RHG, Kelm M, Schauerte P (2009) Regulation of nerve growth factor in the heart: a central role of the calcineurin-NFAT pathway. J. Mol. Cell. Cardiol. 46:568-578. (Impact 5.499)

 

152. Matthijsen RA, de Winther MP, Weber C, Herias V, Gijbels MJ, Buurman WA (2009) Macrophage specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 119:2188-95. (Impact 14.429)

 

153. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, Reiss K, Lindbom L, Weber C, Ludwig A (2009) Regulated  release and functional modulation of junctional adhesion molecule-A by disintegrin metalloproteinases. Blood 113:4799-809. (Impact 10.558)

 

154. Quast T, Tappertzhofen B, Schild C, Grell J, Czeloth N, Förster R, Alon R, Fraemohs L, Dreck K, Weber C, Lämmermann T, Sixt M, Kolanus W (2009) Cytohesin-1 controls the activation of RhoA and modulates integrin-dependent adhesion and migration of dendritic cells. Blood 113:5801-5810. (Impact 10.558)

 

155. Schuh A, Liehn EA, Sasse A, Schneider R, Neuss S, Weber C, Kelm M, Merx MW (2009) Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res. Cardiol. 104:403-11. (Impact 6.128)

 

156. Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Krüttgen A, Weis J, Schwinger RHG, Mischke K, Rassaf T, Kelm M, Schauerte P (2009) The angiotensin II-calcineurin-NFAT-pathway mediates stretch induced up-regulation of matrix metalloproteinases-2 and -9 in atrial cardiomyocytes. Basic Res. Cardiol. 104:435-48. (Impact 6.128)

 

157. Karlmark KR, Weiskirchen R, Henning W. Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T Trautwein C, Tacke F (2009) Hepatic recruit¬ment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50:261-274. (Impact 10.885)

 

158. Shagdarsuren E, Djalali-Talab Y, Liehn EA, Bidzhekov K, Aurrand-Lions M, Imhof BA, Weber C, Zernecke A (2009) Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 29:1161-1163. (Impact 7.215)

 

159. Segerer S, Johnson Z, Rek A, Baltus T, von Hundelshausen P, Kungl AJ, Proudfoot AEI, Weber C*, Nelson PJ* (2009) The basic residue cluster 55KKWVR59 in CCL5 is required for in vivo biologic function. Mol. Immunol. 46:2533-8. *equal contribution. (Impact 2.916)

 

160. Schröder K, Kohnen A, Aicher A, Liehn EA, Büchse T, Stein S, Weber C, Dimmeler S, Brandes RP (2009) The NADPH oxidase Nox2 is required for hypoxia-induced mobilization of endothelial progenitor cells. Circ. Res. 105:537-44. (Impact 9.504)

 

161. Hristov M, Leyendecker T, Schuhmann C, von Hundelshausen P, Krötz F, Sohn HY, Nauwelaers F, Weber C (2009) A refined flow cytometry procedure for the analysis of circulating angiogenic monocytes and endothelial progenitor cells in coronary artery disease. Cytometry 75A:848-853. (Impact 3.749)

 

162. Schwartz V, Lue H, Kraemer S, Krohn R, Ohl K, Korbiel J, Bucala R, Weber C, Bernhagen J (2009) A func¬tio¬nal heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Letters 583:2749-57. (Impact 3.601)

 

163. Goetzenich A, Hatam N, Zernecke A, Weber C, Czarnotta T, Autschbach R, Christiansen S. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig (2009) J. Heart Lung Transplant. 28:1087-93. (Impact 3.426)

 

164. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Nazari Jahantigh M, Lutgens E, Wang S, Olson EN, Schober A, Weber C (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Sign. 2:ra81. (Impact 6.120) (comment in Science 326:1590)

 

2010                       Kum. Impact 184.6

 

165. Hristov M, Gümbel D, Shagdarsuren E, Lutgens E, Zernecke A, Weber C (2010) Soluble CD40 ligand impairs peripheral blood angiogenic outgrowth cell function and increases neointima formation after arterial injury. Circulation 121:315-324. (Impact 14.429) (comment in Circulation 121:197-199)

 

166. Lutgens E, Lievens D, Beckers L, Wijnands E, Soehnlein O, Zernecke A, de Winther M, Engel S, Seijkens T, Boon L, Ahonen C, Noelle R, Daemen M, Biessen EA, Weber C (2010) Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis and skews the immune response towards an anti-inflammatory profile. J. Exp. Med. 207:391-404. (Impact 14.776)

 

167. Braunersreuther V, Pellieux C, Pelli G, Burger F, Steffens S, Montessuit C, Weber C, Proudfoot A, Mach F, Arnaud C (2010) Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in athero¬sclerotic mice. J. Mol. Cell. Cardiol. 48:789-98. (Impact 5.499)

 

168. Zaldivar MM, Pauels K, von Hundelshausen P, Berres ML, Schmitz P, Kowalska MA, Weiskirchen R, Trautwein C, Weber C, Wasmuth HE (2010) A non-redundant role of the platelet-derived chemokine CXCL4 (PF4) in experimental liver fibrosis. Hepatology 51:1345-53. (Impact 10.885)

 

169. Saygili E, Schauerte P, Küppers F, Heck L, Weis J, Weber C, Schwinger RH, Hoffmann R, Schröder JW, Marx N, Rana OR (2010) Electrical stimulation of sympathetic neurons induces autocrine/paracrine effects of NGF mediated by TrkA. J. Mol. Cell. Cardiol. 49:79-87. (Impact 5.499)

 

170. Subramanian P, Karshovska E, Reinhard P, Zhou Z, Megens RTA, Akhtar S, Li X, van Zandvoort M, Ludin C, Weber C, Schober A (2010) Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ. Res. 107:96-105. (Impact 9.504)

 

171. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Mueller-Newen G, Soehnlein O, Weber C (2010) Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122:495-506. (Impact 14.429)

 

172. Goossens P, Gijbels MJJ, Zernecke A, van der Made I, Beckers L, Buurman WA, Daemen MJ, Kalinke U, Weber C, Lutgens E, de Winther MP (2010) Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab. 12:142-153. (Impact 18.207)

 

173. Saygili E, Schauerte P, Küppers F, Heck L, Weis J, Weber C, Schwinger RH, Hoffmann R, Schröder JW, Marx N, Rana OR (2010) Acetylcholine as an age-dependent non-neuronal source in the heart. Auton. Neurosci. 156:82-89. (Impact 1.671)

 

 

174. Hristov M, Leyendecker T, Schuhmann C, von Hundelshausen P, Heussen N, Kehmeier E, Krötz F, Sohn HY, Klauss V, Weber C (2010) Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease. Thromb. Haemost. 104:412-4. (Impact 4.701) (comment in Thromb. Haemost. 2010;104:191-193)

 

175. Shagdarsuren E, Bidzhekov K, Mause S, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A, Weber C (2010) C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 122:1026-1036. (Impact 14.429)

 

176. Berres ML, Rueland A, Koenen RR, Moreno Zaldivar M, Schmitz P, Streetz KL, Gassler N, Weiskirchen R,  Weber C, Trautwein C, Wasmuth HE (2010) Antagonism of the chemokine CCL5 (RANTES) ameliorates experimental liver fibrosis in vivo. J. Clin. Invest. 120:4129-40. (Impact 14.152)

 

177. Drechsler M, Megens R, van Zandvoort M, Weber C, Soehnlein O (2010) Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis in mice. Circulation 122:1837-45. (Impact 14.429)

 

178. Lievens D, Zernecke A, Seijkens T, Beckers L, Munnix ICA, Wijnands E, Flavell RA, Noelle RJ, Biessen EA, Daemen MJAP, Heemskerk JWM, Weber C, Lutgens E (2010) Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116:4317-27. (Impact 10.558)

 

179. Liehn EA, Piccinini A, Koenen RR, Soehnlein O, Adage T, Fatu R, Curaj A, Popescu A, Zernecke A, Kungl A, Weber C (2010) A potent CCL2 antagonist suitable for combined treatment of vascular and ischemia-reperfusion injury. J. Am. Coll. Cardiol. 56:1847-57. (Impact 14.292)

 

180. Schwarz N, Pruessmeyer J, Hess MF, Pantaler E, Windoffer R, Voss M, Sarabi A, Weber C, Secchi AS,  Uhlig S, Ludwig A (2010) Stepwise leukocyte recruitment via the transmembrane chemokine CX3CL1. Cell. Mol. Life Sci. 67:4233-48. (Impact 7.047)

 

181. Ren M, Guo Q, Guo L, Lenz M, Qian F, Koenen RR, Xu H, Schilling AB, Weber C, Ye RD, Dinner AR, Tang WJ (2010) Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin degrading enzyme. EMBO J. 29:3952-3966. (Impact 10.124)

 

 

2011                     

 

182. Sarabi A, Kramp B, Weber C, Koenen R, von Hundelshausen P (2011) CXCL4L1 inhibits angiogenesis and induces undirected endothelial migration without affecting proliferation or monocyte recruitment. J. Thromb. Haemost. 9:209-19. (Impact 5.439)

 

183. Saygili E, Schauerte P, Pekassa M, Saygili E, Rackauskas G, Schwinger RHG, Weis J, Weber C, Marx N, Rana OR (2011) Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cell. Mol. Neurobiol. 31:17-25. (Impact 2.423)

 

184. de Jager SC, Bermúdez B, Bot I, Koenen RR, Bot M, Kavelaars A, de Waard V, Heijnen CJ, Muriana FJ, Weber C, van Berkel TJ, Kuiper J, Lee SJ, Abia R, Biessen EA (2011) Growth differentiation factor-15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J. Exp. Med. 208:217-25. (Impact 14.776)

 

185. Schober A, Hristov M, Forbrig R, Kofler S, Löhr B, Schumann U, Krötz F, Leibig M, König A, Kazcmerek I, Reichart B, Klauss V, Weber C, Sohn HY (2011) Smooth muscle progenitor cells and CXCL12 predict the severity of cardiac allograft vasculopathy. Eur. Heart J. 32:476-84. (Impact 10.046)

186. Kraemer S, Lue H, Zernecke A, Kapurniotu A, Andreetto E, Frank R, Lennartz B, Weber C, Bernhagen J (2011) MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based two-site binding mechanism. FASEB J. 25:894-906. (Impact 6.515)

 

187. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G (2011) Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J. Cell. Mol. Med. 15:668-678. (Impact 4.608)

 

188. Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Reinholz M, van Zandvoort M, Weber C, Schober A (2011) Lipoprotein-derived lysophosphatidic acid enhances atherosclerosis through the release of CXCL1 from endothelium. Cell Metab. 13:592-600. (Impact 18.207)

 

189. Rana OR, Saygili E, Buhr A, Saygili E, Gemein C, Mischke K, Nolte KW, Weis J, Weber C, Marx N, Schauerte P (2011) Chronic electrical neuronal stimulation increases cardiac parasympathetic tone by eliciting neurotrophic effects. Circ. Res. 108:1209-19. (Impact 9.504)

 

190. Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens R, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van Zandvoort M, Binder C, Jelinek Y, Hristov M, Boon L, Jung S, Korn T, Lutz MB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A (2011) CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T-cell homeostasis in mice. J. Clin. Invest. 121:2898–2910. (Impact 14.152)

 

191. Rowinska Z, Zander S, Zernecke A, Jacobs M, Langer S, Weber C, Merx MW, Koeppel TA (2011) Non-invasive in vivo analysis of a murine aortic graft using high resolution ultrasound microimaging. Eur. J. Radiol., in press. (Impact 2.941)

 

192. Poggi, Engel D, Christ A, Beckers L, Wijnands E, Boon L, Driessen A, Cleutjens J, Weber C, Gerdes N, Lutgens E (2011) CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice, Arterioscler. Thromb. Vasc. Biol., in press. (Impact 7.215)

 

193. Soehnlein O, Wantha S, Simsekyilmaz S, Doering Y, Megens RT, Mause SF, Drechsler M, Smeetz R, Weinandy S, Schreiber F, Gries T, Vijayan S, van Zandvoort M, Agerberth B, Pham CT, Gallo RL, Hackeng TM, Liehn EA, Hristov M, Zernecke A, Klee D, Weber C (2011) Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Science Transl. Med., in press. (Impact 3.511)

 

194. Liehn E, Tuchscheerer N, Kanzler I, Drechsler M, Fraemohs L, Schuh A, Koenen R, Zandler S, Soehnlein O, Hristov M, Grigorescu G, Urs A, Leabu M, Bucur I, Merx M, Zernecke A, Bernhagen J, Schober A, Weber C (2011) Double-edged role of the CXCL12-CXCR4 axis in experimental myocardial infarction. J. Am. Coll. Cardiol., in press. (Impact 14.292)

 

195. Schwartz V, Krüttgen A, Weis J, Weber C, Ostendorf T, Lue H, Bernhagen J (2011) Role for CD74 and CXCR4 in clathrin-dependent endocytosis. Eur. J. Cell Biol., in press. (Impact 2.736)

 

196. Vasina EM, Cauwenberghs S, Feijge MAH, Heemskerk JWM, Weber C, Koenen RR (2011) Microparticles from apoptotic platelets promote resident monocyte subset differentiation. Cell Death Dis., in press. (Impact 0.200)

 

197. Butoi E, Gan AM, Manduteanu I, Stan D, Calin M, Pirvulescu M, Koenen RR, Weber C, Simionescu M (2011) Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. BBA Mol. Cell Res., in press. (Impact 4.733)

 

198. Heinrichs D, Jung J, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Trautwein C, Bucala R, Weber C,  Bernhagen J, Wasmuth HE (2011) Macrophage migration inhibitory factor (MIF) exerts anti-fibrotic effects in experimental liver fibrosis via CD74. Proc. Natl. Acad. Sci. USA., in press. (Impact 9.771)

 

 

Übersichtsartikel, Kommentare und Methodenprotokolle

1993-2000           Kum. Impact 18.3

1. Sellmayer A, Obermeier H, Weber C, Weber PC (1993) Modulation of cell activation by n-3 fatty acids. In n-3 Fatty Acids and Vascular Disease, Springer Verlag, pp. 21-30. (Impact 0.500)

 

2. Weber C (1996) Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunol. Res. 15:30-37. (Impact 3.383)

 

3. Weber C, Erl W, Weber KSC, Weber PC (1999) Effects of oxidzied LDL, lipid mediators and statins on vascular cell interactions. Clin. Chem. Lab. Med. 37:243-251. (Impact 2.069)

 

4. Gröne HJ, Weber C, Weber KS, Grone EF, Klier CM, Wells TN, Proudfoot AE, Schlöndorff D, Nelson PJ (1999) Reduction of acute kidney transplantation rejection by the chemokine receptor antagonist Met-RANTES. Verh. Dtsch. Ges. Pathol. 1999;83:205-11. (Impact 0.400)

 

5. Weber C, Erl W (2000) Modulation of vascular cell activation, function and apoptosis by antioxidants. Curr. Top. Cell Reg. 36:217-235. (Impact 4.450)

 

6. Hengel H, Weber C (2000) Driving cells into atherosclerotic lesions: a deleterious role of viral chemokine receptors? Trends Microbiol. 8:294-296. (Impact 7.500)

 

2001-2003           Kum. Impact 15.6

 

7. Neuzil J, Weber C, Kontusch A (2001) Vitamin E in atherosclerosis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157:257-283. (Impact 4.086)

 

8. Neuzil J, Terman A, Weber C, Brunk U (2001) Vitamin E analogs as inducers of apoptosis: implications for their potential antineoplastic role. Redox Report 6:143-151. (Impact 1.514)

 

9. Zernecke A, Weber C (2001) Glomeruläre Verkehrskontrolle: sequentielle Regulation der glomerulären Infiltration mit Monozyten durch spezialisierte Chemokine. Immunologie Aktuell 2001;2:30-31. (Impact 0.400)

 

10. Neuzil J, Kagedal K, Andera L, Weber C, Brunk U (2002) Vitamin E analogues: a novel class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7:177-185. (Impact 4.397)

 

11. Weber C (2003) Novel mechanistic concepts for the control of leukocyte transmigration; spezialisation of integrins, chemokines and junctional molecules. J. Mol. Med. 81:4-19. (Impact 5.192)

 

2004           Kum. Impact 31.0

 

12. Radke P*, Weber C*, Kaiser A, Schober A, Hoffmann R, (2004) Dexamethasone and related compounds for local drug delivery using coated stents: new indications for an old drug. Curr. Pharm. Des.10:349-355 (* equal contribution). (Impact 4.774)

 

13. Weber C, Zernecke A, Schober A (2004) Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24:1997-2008. (Impact 7.215)

 

14. Merx MW, Lin E, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C (2004) Simvastatin and survival in sepsis. Circulation 110:e315. (Impact 14.429)

 

15. Hristov M, Weber C (2004) Endothelial progenitor cells: pathophysiological aspects and possible clinical relevance. J. Cell. Mol. Med. 8:498-508. (Impact 4.608, 152 Zitationen)

 

2005           Kum. Impact 31.1

 

16. Zernecke A, Weber C (2005) Inflammatory mediators of atherosclerotic vascular disease. Basic Res. Cardiol. 100:93-101. (Impact 6.128)

 

17. Weber C (2005) Plalelets and chemokines in atherosclerosis: partners in crime. Circ. Res. 96:612-616. (Impact 9.504)

 

18. Schober A, Weber C (2005) Mechanisms of monocyte recruitment in vascular repair after injury. Antioxid. Redox Signal. 7:1249-57. (Impact 8.209)

 

19. Weber C (2005) Killing two birds with one stone: targeting chemokine receptors in atherosclerosis and HIV. Arterioscler. Thromb. Vasc. Biol. 25:2448-2450. (Impact 7.215)

 

2006                      Kum. Impact 70.0

 

20. Hristov M, Weber C (2006) The therapeutic potential of progenitor cells in ischemic heart disease: past, present and future. Basic Res. Cardiol. 101:1-7. (Impact 6.128)

 

21. Merx M, Weber C (2006) Statins: a preventive strike against infection-related mortality in patients with cardiovascular disease? Lancet 367:372-373. (Impact 33.633)

 

22. Radke PW, Hoffmann R, Zernecke A, Kaiser A, Schunkert H, Weber C (2006) Thienopyridines in per¬cutaneous coronary interventions: bare metal stents, drug eluting stents and brachytherapy. Curr. Pharm. Des. 12:1281-1286. (Impact 4.774)

 

23. Hristov M, Keymel S, Weber C (2006) The therapeutic effect of autologous bone marrow cells in ischemic heart disease. Med. Klinik 101:186-189. (Impact 0.447)

 

24. Bidzhekov K, Zernecke A, Weber C (2006) MCP-1 induces a novel transcription factor with proapoptotic activities. Circ Res. 98:1107-1109. (Impact 9.504)

 

25. Schober A, Karshovska E, Zernecke A, Weber C (2006) SDF-1-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? Trends Cardiovasc. Med. 16:103-108. (Impact 3.250)

 

26. Weber C, Koenen R (2006) Fine-tuning leukocyte responses: towards a chemokine interactome. Trends Immunol. 27:268-73. (Impact 9.533)

 

27. Merx M, Weber C (2006) Statins in the intensive care unit. Curr. Opin. Crit. Care 12:309-14. (Impact 2.551)

 

28. Liehn EA, Zernecke A, Postea O, Weber C (2006) Chemokines: inflammatory mediators of atherosclerosis. Arch. Physiol. Biochem. 112:229-238. (Impact 0.200)

 

2007         Kum. Impact 114.6

 

29. von Hundelshausen P, Weber C (2007) Platelets as immune cells: bridging inflammation and vascular disease. Circ. Res. 100:27-40. (Impact 9.504)

 

30. Weber C, Schober A (2007) MIF and atherosclerosis. In MIF: A Most Interesting Factor, edited by R. Bucala, World Scientific Publishing, p. 217-228. (Impact 0.500)

 

31. Koenen RR, von Hundelshausen P, Weber C (2007) Inflammatory blues turns velvet skin into rawhide: monocyte rolling on modified endothelial PSGL-1. Arterioscler. Thromb. Vasc. Biol. 27:990-992. (Impact 7.215)

 

32. Weber C (2007) Chemokines take centre stage in vascular biology. Thromb. Haemostasis 97:685-687. (Impact 4.701)

 

33. Ludwig A, Weber C (2007) Transmembrane chemokines: versatile special agents in vascular inflammation. Thromb. Haemostasis 97:694-703. (Impact 4.701)

 

34. Weber C, Fraemohs L, Dejana E (2007) The role of junctional adhesion molecules in vascular inflammation. Nature Rev. Immunol. 7:467-477. (Impact 35.196)

 

35. Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116:782-792. (Impact 14.429)

 

36. Hristov M, Zernecke A, Liehn EA, Weber C (2007) Mechanisms of endothelial regeneration after arterial injury. Thromb. Haemostasis 98:274-277. (Impact 4.701)

 

37. Krohn R, Weber C, Bernhagen J (2007) Flow chamber adhesion assay for measuring arrest function of chemokines. Nature Protocols DOI:10.1038/nprot.2007.189 (Impact 8.362)

 

38. Krohn R, Koenen RR, Weber C, Bernhagen J (2007) Alpha-L beta-2 integrin activation on MonoMac6 cells. Nature Protocols DOI:10.1038/nprot.2007.190 (Impact 8.362)

 

39. Krohn R, Koenen RR, Bernhagen J, Hristov M, Georgiev IT, Weber C (2007) FACS-based calcium mobilization assay. Nature Protocols DOI:10.1038/¬nprot.2007.212. (Impact 8.362)

 

40. Lue H, Dewor M, Weber C, Bernhagen J (2007) Receptor internalization assay to probe for agonist binding to CXCR2. Nature Protocols DOI:10.1038/¬nprot.2007.213. (Impact 8.362)

 

41. Koenen RR, von Hundelshausen P, Weber C (2007) Antagonism of chemokine receptors as a novel therapeutic approach in the combined treatment of viral and atherosclerotic disease.  J. Viral Entry 3:20-25. (Impact 0.200)

 

2008         Kum. Impact 119.2

 

42. Weber C (2008) Cell-cell interactions in the vascular wall. Nova Acta Leopoldina 351:83-7. (Impact 0.200)

 

43. Zernecke A, Bernhagen J, Weber C (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117:1594-1602. (Impact 14.429)

 

44. Schober A, Bernhagen J, Weber C (2008) Chemokine-like functions of MIF in atherosclerosis. J. Mol. Med. 86:761-70. (Impact 5.192)

 

45. Krohn R, Bernhagen J, Weber C (2008) MIF – ein neuer Protagonist in der Atherosklerose. Laborwelt 9:6-9. (Impact 0.200)

 

46. Hristov M, Zernecke A, Schober A, Weber C (2008) Adult progenitor cells in vascular remodeling during atherosclerosis. Biol. Chem. 398:837-844. (Impact 3.603)

 

47. Schober A, Weber C (2008) Leptin and EPCs: yes, we can. Circ. Res. 103:447-449. (Impact 9.504)

 

48. Hristov M, Weber C (2008) Ambivalence of progenitor cells in vascular repair and plaque stability. Curr. Opin. Lipidol. 19:491-497. (Impact 6.636)

 

49. Weber C, Zernecke A, Libby P (2008) The multi-facetted contributions of leukocyte subsets to athero¬sclerosis. Nature Rev. Immunol. 8:802-815. (Impact 35.196)

 

50. Hristov M, Weber C (2008) Endothelial progenitor cells in vascular repair and remodeling. Pharmacol. Res. 58:148-51. (Impact 3.612)

 

51. Weber C (2008) Chemokines in Atherosclerosis, Thrombosis & Vascular Biology: Introduction to the Weber series. Arterioscler. Thromb. Vasc. Biol. 28:1896. (Impact 7.215)

 

52. Zernecke A, Shagdarsuren E, Weber C (2008) Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28:1897-1908. (Impact 7.215)

 

53. Weber C (2008) Frontiers and novel targets in molecular cardiology. Drug Discov. Today Dis. Mech. 5:e265-266. (Impact 6.422)

 

54. Hristov M, Weber C (2008) Endothelial progenitor cells: cellular biomarkers in vascular disease. Drug Discov. Today Dis. Mech. 5:e267-271. (Impact 6.422)

 

55. Shagdarsuren E, Müller D, Weber C, Zernecke A (2008) Complement activation in vascular remodeling and organ damage. Drug Discov. Today Dis. Mech. 5:e299-306. (Impact 6.422)

 

56. Merx MW, Weber C (2008) Benefits of statins beyond lipid lowering. Drug Discov. Today Dis. Mech. 5:e325-331. (Impact 6.422)

 

57. Weber C (2008) Chemokin-artige Funktionen von MIF in der Atherosklerose. In Neue Aspekte der Arterio¬sklerose¬forschung, ISBN 978-3-936423-07-5, edited by: H. Heinle et al., p. 1-6 (Impact 0.500)

 

2009         Kum. Impact 117.9

 

58. von Hundelshausen P, Weber C (2009) Platelet-mediated enhancement of monocyte and leukocyte adhesion. Microcirculation 16:84-96. (Impact 2.533)

 

59. Mause S, Weber C (2009) Intrusion through the fragile back door – immature plaque microvessels as entry portals for leukocytes and erythrocytes in atherosclerosis. J. Am. Coll. Cardiol. 53:1528-31. (Impact 14.292)

 

60. Taylor J, Weber C (2009) Spotlight: Christian Weber, MD, FESC. Circulation 119:f139-f141. (Impact 14.429)

 

61. Taylor J, Weber C (2009) Team 2009: Institute for Molecular Cardiovascular Research, Aachen, Germany. Circulation 119:f142-f143. (Impact 14.429)

 

62. Taylor J, Weber C (2009) Initiatives in Cardiovascular Research: The Euregio Cardiovascular Research School. Circulation 119:f144. (Impact 14.429)

 

63. Soehnlein O, Weber C (2009) Myeloid cells in atherosclerosis: initiators and decision shapers. Semin. Immunopathol. 31:35-47. (Impact 5.216)

 

64. Koenen RR, Weber C (2009) Co-immunoprecipitation of platelet factor 4 and RANTES from human platelets. Nature Protocols 10.1038/nprot.2009.132. (Impact 8.362)

 

65. Hristov M, Weber C (2009) Progenitor cell trafficking in the vascular wall. J. Thromb. Haemost. 7:31-34. (Impact 5.439)

 

66. Noels H, Bernhagen J, Weber C (2009) MIF: a non-canonical chemokine important in atherosclerosis. Trends Cardiovas. Dis. 19:76-86. (Impact 4.121)

 

67. Weber C (2009) Frontiers in vascular biology: mechanisms of inflammation and immunoregulation in arterial remodelling. Thromb. Haemost. 102:188-90. (Impact 4.701)

 

68. Soehnlein O, Zernecke A, Weber C (2009) Neutrophils launch monocyte extravasation by release of granule proteins. Thromb. Haemost. 102:198-205. (Impact 4.701)

 

69. Soehnlein O, Weber C, Lindbom L (2009) Neutrophil granule proteins tune monocytic cell function. Trends Immunol. 30:538-46. (Impact 9.533)

 

70. Soehnlein O, Lindbom L, Weber C (2009) Neutrophils and the control of monocyte extravasation. Blood 114:4613-23. (Impact 10.558)

 

71. Weber C (2009) Monozyten und Leukozyten. In Hämostaseologie, Springer Verlag (ISBN: 978-3-642-01543-4) page 105-112. (Impact 0.500)

 

72. Soehnlein O, Drechsler M, Hristov M, Weber C (2009) Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis. J. Cell. Mol. Med. 13:4293-4303. (Impact 4.608)

 

2010         Kum. Impact 113.8

 

73. Weber C, Lip GYH (2010) Moving forwards with a new Editorial team for Thrombosis and Haemostasis. Thromb. Haemost. 103:1-2. (Impact 4.701)

 

74. Lip GYH, Preissner KT, Weber C (2010) Editor’s choice articles 2008-2009. Thromb. Haemost. 103:3-6. (Impact 4.701)

 

75. Koenen RR, Weber C (2010) Therapeutic targeting of chemokine interactions in atherosclerosis. Nat. Rev. Drug Discov. 9:141-53. (Impact 28.719)

 

76. Lutgens E, Poggi M, Weber C (2010) CD40-CD40L fuel ignites obesity. Thromb. Haemost. 103:694-5. (Impact 4.701)

 

77. Koenen RR, Weber C (2010) Manipulating the chemokine system: Therapeutic perspectives for atherosclerosis. Curr. Opin. Investig. Drugs 11:265-72. (Impact 3.395)

 

78. Noels H, Weber C (2010) Fractalkine as an important target of aspirin in the prevention of atherogenesis. Cardiovasc. Drugs Ther. 24:1-3. (Impact 3.098)

 

79. Koenen RR, Weber C (2010) Platelet-derived chemokines in vascular remodeling and atherosclerosis. Semin. Thromb. Hemost. 36:163-9. (Impact 4.169)

 

80. Zernecke A, Weber C (2010) Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc. Res. 86:192-201. (Impact 6.051)

 

81. Lievens D, Gerdes N, Schober A, Weber C (2010) Atherosclerosis: cell biology and lipoproteins. Curr. Opin. Lipidol. 21:284-285. (Impact 6.636)

 

82. Weber C, Schober A, Zernecke A (2010) MicroRNAs in arterial remodelling, inflammation and athero¬sclerosis. Curr. Drug Targets 11:950-6. (Impact 3.061)

 

83. Weber C (2010) Obstacles and options in cardiovascular drug development. Thromb. Haemost. 104:1-3. (Impact 4.701)

 

84. Weber C (2010) Far from the heart: receptor cross-talk in remote conditioning. Nat. Med. 16:760-762. (Impact 25.430)

 

85. Mause SF, Sampol J, Weber C, Dignat-George F (2010). Thromb. Haemost. 104:421-3. (Impact 4.701)

 

86. Mause SF, Weber C (2010) Microparticles - protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107:1047-57. (Impact 9.504)

 

87. Vasina E, Heemskerk JW, Weber C, Koenen RR (2010) Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets. 9:346-54. (Impact 0.200)

 

2011

 

 

88. Weber C, Lip GYH (2011) Commencing 2011 with Thrombosis and Haemostasis - and looking to the future. Thromb. Haemost. 105:1-2. (Impact 4.701)

 

89. Lip GYH, Weber C (2011) Clinical and basic science articles from Thrombosis and Hameostasis. Thromb. Haemost. 105:202-5. (Impact 4.701)

 

90. Kramp B, Sarabi A, Koenen RR, Weber C (2011) Heterophilic chemokine receptor interactions in chemokine signaling and biology. Exp. Cell Res. 317:655-663. (Impact 3.609)

 

91. Noels H, Weber C (2011) Catching up with important players in atherosclerosis: type I interferons and neutrophils. Curr. Opin. Lipidol. 22:144-5. (Impact 6.636)

 

92. Megens R, Kemmrich K, Pyta J, Weber C, Soehnlein O (2011) Intravital imaging of phagocyte recruitment. Thromb. Haemost. 105:802-10. (Impact 4.701)

 

93. Schober A, Weber C (2011) Bone marrow-derived smooth muscle cells are breaking bad in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31:1258-9. (Impact 7.215)

 

94. Ylä-Herttuala S, Bentzon JF, Daemen MJAP, Falk E, Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak B, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PWJC, Waltenberger J, Weber C, Tokgözoglu L (2011) Stabilisation of atherosclerotic plaques. Thromb. Haemost. 106:1-19. (Impact 4.701)

 

95. Kanzler I, Liehn EA, Koenen RR, Weber C (2011) Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications. Curr. Pharmaceut. Biotechnol., in press. (Impact 3.455)

 

96. Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med., in press. (Impact 25.430)

 

97. Weber C, Soehnlein O (2011) ApoE controls the interface linking lipids and inflammation in atherosclerosis. J. Clin. Invest., in press. (Impact 14.152)

 

98. Noels H, Bernhagen J, Weber C (2011) MIF in atherosclerosis. In MIF: Most Interesting Factor revisited, edited by R. Bucala, World Scientific Publishing. (Impact 0.500)

 

99. Raffetseder U, Liehn EA, Weber C, Mertens PR (2011) Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejection. Eur. J. Cell Biol., in press. (Impact 2.736)

 

100. Koenen RR, Weber C (2011) Chemokines: new targets in atherosclerosis. EMBO Mol. Med., in press. (Impact 8.830)

 

101. Hristov M, Weber C (2011) Differential role of monocyte subsets in atherosclerosis. Thromb. Haemost., in press. (Impact 4.701)

 

102. Schober A, Zhe Z, Weber C (2012) Smooth muscle progenitor cells: A novel target for the treatment of vascular disease? In Muscle: Fundamental biology and mechanisms of disease, in press. (Impact 0.500)

 

103. Ylä-Herttuala S, Bentzon JF, Daemen MJ, Falk E, Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R,

Kwak B, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys P, Waltenberger J, Weber C, Tokgözoglu L (2012) Stabilising atherosclerotic plaques: executive summary. Eur. Heart J., in revision. (Impact 10.046)

 

104. Noels H, Doering Y, Weber C (2012) The use of high-throughput technologies to investigate inflammatory pathways in vascular cells. Arterioscler. Thromb. Vasc. Biol., invited. (Impact 7.215)

 

105. Raffetseder U, Liehn EA, Weber C, Mertens PR (2011) Role of cold shock Y-box protein-1 in inflammation, atherosclerosis and organ transplant rejection.Eur J Cell Biol. (Impact 3,630)

 

106. Vasina EM, Cauwenberghs S, Feijge MA, Heemskerk JW, Weber C, Koenen RR (2011) Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis.

 

 

 
 
IPEKlogo

Direktor: Prof. Dr. med. Christian Weber

Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten (IPEK)

 

Pettenkoferstraße 8a & 9

80336 München

 

Tel.: 089-4400-54351

Fax: 089-4400-54352

Mail: Kreislaufinstitut@med.uni-muenchen.de

 

Veranstaltungen

Links